2-Methoxyresorcinol

2-Methoxyresorcinol

SCHEMBL69297

COc1c(O)cccc1O

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 5/20 0.61
CA1 P00915 5/20 0.61
ALDH1A1 P00352 4/20 0.56
KDM4E B2RXH2 3/20 0.56
LMNA P02545 3/20 0.56
HPGD P15428 3/20 0.56
ALOX15 P16050 3/20 0.56
HSD17B10 Q99714 3/20 0.56
CYP3A4 P08684 3/20 0.56
MAPT P10636 3/20 0.56
TP53 P04637 2/20 0.56
MAPK1 P28482 2/20 0.56
ALOX12 P18054 1/20 0.56
TDP1 Q9NUW8 3/20 0.55
TSHR P16473 1/20 0.52
CA12 O43570 3/20 0.48
CA14 Q9ULX7 2/20 0.48
CA7 P43166 2/20 0.48
CA9 Q16790 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
2-Methoxyresorcinol SCHEMBL10818280 0.97 CA2 (0.59) CA2CA1ALDH1A1KDM4ELMNA
SCHEMBL21815270 0.87 CA1 (0.55) CA2CA1ALDH1A1KDM4ELMNA
SCHEMBL186826 0.85 MAPT (0.67) CA2CA1ALDH1A1KDM4ELMNA
SCHEMBL557811 0.85 CA1 (0.53) CA2CA1ALDH1A1KDM4ELMNA
SCHEMBL2575946 0.83 CA1 (0.52) CA2CA1ALDH1A1KDM4ELMNA
SCHEMBL3889690 0.83 MAPT (0.64) CA2CA1ALDH1A1KDM4ELMNA
SCHEMBL30973506 0.83 CA2 (0.52) CA2CA1ALDH1A1KDM4ELMNA
Hydrochloric Acid SCHEMBL22291108 0.83 TP53 (0.64) CA2CA1ALDH1A1KDM4ELMNA
SCHEMBL3898449 0.83 MAPT (0.64) CA2CA1ALDH1A1KDM4ELMNA
SCHEMBL30356573 0.83 CA1 (0.52) CA2CA1ALDH1A1KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 523 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118549543-B Multicomponent foreign matter for detecting authenticity of betel nut honey as well as acquisition method and application thereof 中国农业科学院蜜蜂研究所 2025-01-24 CN claimed
CN-118549543-A Multicomponent foreign matter for detecting authenticity of betel nut honey as well as acquisition method and application thereof 中国农业科学院蜜蜂研究所 2024-08-27 CN claimed
EP-3645492-B1 PREPARATION PROCESS OF ORTHO ALKOXY BISPHENOL MONOMERS UNIV LEUVEN KATH (BE) 2024-08-21 EP claimed
CN-116648480-A Lignin composition and use thereof 出光兴产株式会社 2023-08-25 CN claimed
CN-110809570-B Preparation method of ortho-alkoxy bisphenol monomer 鲁汶天主教大学 2023-06-23 CN claimed
US-11414519-B2 Ortho alkoxy bisphenol monomers KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2022-08-16 US claimed
CN-113278532-B Alternaria tenuissima and metabolite and application thereof 山东农业大学 2022-03-29 CN claimed
CN-113896701-A Synthesis process of Hsp90 inhibitor KU-177 南京中医药大学 2022-01-07 CN claimed
CN-113243391-B Sterilization composition containing Taishan mycin 山东农业大学 2021-11-02 CN claimed
CN-113278532-A Alternaria tenuissima and metabolite and application thereof 山东农业大学 2021-08-20 CN claimed
EP-2547379-A1 MOLECULARLY IMPRINTED POLYMERS FOR ELIMINATING METABOLITES Fresenius Medical Care Deutschland GmbH (DE) 2013-01-23 EP claimed
US-20130011364-A1 MOLECULARLY IMPRINTED POLYMERS FOR ELIMINATING METABOLITES FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH (DE) 2013-01-10 US claimed
WO-2011113607-A1 MOLECULARLY IMPRINTED POLYMERS FOR ELIMINATING METABOLITES FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH (DE) 2011-09-22 WO claimed
US-20100300472-A1 METHOD FOR STRAIGHTENING KERATINOUS FIBERS USING HEATING MEANS AND AN AROMATIC COMPOUND L'OREAL S.A. (FR) 2010-12-02 US claimed
US-20050080260-A1 Preparation of prodrugs for selective drug delivery LUMINIDE 2005-04-14 US claimed
CN-1117768-C Process for preparation of dispersions of water-soluble polymers HYMO CORP (JP) 2003-08-13 CN claimed
CN-1248265-A Process for producing water-soluble polymer dispersions HYMO CORP (JP) 2000-03-22 CN claimed
EP-0239423-A2 Positive type radiation-sensitive resin composition JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1987-09-30 EP claimed
EP-0088023-B1 PYRIDO(3',4':4,5)FURO(3,2-G) COUMARINES OR PYRIDO(3,4-H)PSORALENES, PREPARATION, USE IN COSMETOLOGY AND AS MEDICAMENTS AND COMPOSITIONS CONTAINING THEM INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 1987-01-14 EP claimed
US-4473713-A Hydrolysis of aryl-aliphatic ethers RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1984-09-25 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050080260-A1 Preparation of prodrugs for selective drug delivery APEH, PAH, ALAD CA2 3018/4885CA1 2423/4885ALDH1A1 61/4885
US-11414519-B2 Ortho alkoxy bisphenol monomers ALK, ESR1, ADIPOR1 CA2 1098/4885CA1 3743/4885ALDH1A1 354/4885
US-20100300472-A1 METHOD FOR STRAIGHTENING KERATINOUS FIBERS USING HEATING MEANS AND AN AROMATIC COMPOUND KRT18, TUBB4A, TUBB4B CA2 2393/4885CA1 2454/4885ALDH1A1 1099/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.